Impact of availability of anti–vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration
JP Campbell, SB Bressler… - Archives of …, 2012 - jamanetwork.com
Methods. In this retrospective cohort study, all cases of choroidal neovascularization
secondary to AMD seen by 2 of us (NMB and SBB) in 2002 and 2008 were identified from
record review and billing records. All eyes with incident neovascular AMD and at least 12
months of follow-up were included. Records were reviewed for baseline demographic
variables, types of treatment received, and follow-up visual acuity (VA) at 24 (±6) months.
For patients with follow-up less than 19 months, 2-year data were imputed with the last …
secondary to AMD seen by 2 of us (NMB and SBB) in 2002 and 2008 were identified from
record review and billing records. All eyes with incident neovascular AMD and at least 12
months of follow-up were included. Records were reviewed for baseline demographic
variables, types of treatment received, and follow-up visual acuity (VA) at 24 (±6) months.
For patients with follow-up less than 19 months, 2-year data were imputed with the last …